313 related articles for article (PubMed ID: 34943104)
1. The Synbiotic Combination of
Juárez-Fernández M; Porras D; Petrov P; Román-Sagüillo S; García-Mediavilla MV; Soluyanova P; Martínez-Flórez S; González-Gallego J; Nistal E; Jover R; Sánchez-Campos S
Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943104
[TBL] [Abstract][Full Text] [Related]
2. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease.
Petrov PD; García-Mediavilla MV; Guzmán C; Porras D; Nistal E; Martínez-Flórez S; Castell JV; González-Gallego J; Sánchez-Campos S; Jover R
Mol Nutr Food Res; 2019 Oct; 63(20):e1900487. PubMed ID: 31322321
[TBL] [Abstract][Full Text] [Related]
3. Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis.
Rao Y; Kuang Z; Li C; Guo S; Xu Y; Zhao D; Hu Y; Song B; Jiang Z; Ge Z; Liu X; Li C; Chen S; Ye J; Huang Z; Lu Y
Gut Microbes; 2021; 13(1):1-19. PubMed ID: 34030573
[TBL] [Abstract][Full Text] [Related]
4. Heat-Inactivated
Morrison MC; Gart E; Duyvenvoorde WV; Snabel J; Nielsen MJ; Leeming DJ; Menke A; Kleemann R
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216439
[TBL] [Abstract][Full Text] [Related]
5. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
7. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.
Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920
[TBL] [Abstract][Full Text] [Related]
8. Akkermansia muciniphila alleviates high-fat-diet-related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids.
Wu W; Kaicen W; Bian X; Yang L; Ding S; Li Y; Li S; Zhuge A; Li L
Microb Biotechnol; 2023 Oct; 16(10):1924-1939. PubMed ID: 37377410
[TBL] [Abstract][Full Text] [Related]
9. Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis.
Kim S; Lee Y; Kim Y; Seo Y; Lee H; Ha J; Lee J; Choi Y; Oh H; Yoon Y
Appl Environ Microbiol; 2020 Mar; 86(7):. PubMed ID: 31953338
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
[TBL] [Abstract][Full Text] [Related]
11.
Nian F; Wu L; Xia Q; Tian P; Ding C; Lu X
J Clin Transl Hepatol; 2023 Aug; 11(4):763-776. PubMed ID: 37408808
[TBL] [Abstract][Full Text] [Related]
12. Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice.
Yavorov-Dayliev D; Milagro FI; Ayo J; Oneca M; Goyache I; López-Yoldi M; Aranaz P
Diabetologia; 2023 Nov; 66(11):2117-2138. PubMed ID: 37584728
[TBL] [Abstract][Full Text] [Related]
13. MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila.
Zhang L; Wang Y; Wu F; Wang X; Feng Y; Wang Y
Int J Biol Macromol; 2022 Jan; 196():23-34. PubMed ID: 34920070
[TBL] [Abstract][Full Text] [Related]
14. Role of Probiotics in Gut Microbiome and Metabolome in Non-Alcoholic Fatty Liver Disease Mouse Model: A Comparative Study.
Wu T; Zeng Z; Yu Y
Microorganisms; 2024 May; 12(5):. PubMed ID: 38792849
[TBL] [Abstract][Full Text] [Related]
15. Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity.
Sergeev IN; Aljutaily T; Walton G; Huarte E
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952249
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
[TBL] [Abstract][Full Text] [Related]
17. Increase of
Nishiyama M; Ohtake N; Kaneko A; Tsuchiya N; Imamura S; Iizuka S; Ishizawa S; Nishi A; Yamamoto M; Taketomi A; Kono T
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32245128
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models.
Su D; Nie Y; Zhu A; Chen Z; Wu P; Zhang L; Luo M; Sun Q; Cai L; Lai Y; Xiao Z; Duan Z; Zheng S; Wu G; Hu R; Tsukamoto H; Lugea A; Liu Z; Pandol SJ; Han YP
Front Physiol; 2016; 7():498. PubMed ID: 27895587
[TBL] [Abstract][Full Text] [Related]
19.
Banerjee G; Papri SR; Satapathy SK; Banerjee P
Curr Pharm Biotechnol; 2024; 25(4):426-433. PubMed ID: 37724669
[TBL] [Abstract][Full Text] [Related]
20. Fasting and refeeding triggers specific changes in bile acid profiles and gut microbiota.
Zhang Y; Qi H; Wang L; Hu C; Gao A; Wu Q; Wang Q; Lin H; Chen B; Wang X; Wang S; Lin H; Wang W; Bi Y; Wang J; Lu J; Liu R
J Diabetes; 2023 Feb; 15(2):165-180. PubMed ID: 36682739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
